The leading cause of cancer related deaths world wide is Pancreatic Cancer. The disease has a very poor prognosis and carries a virtual death sentence along with it. In the United States alone, 33,000 new cases of pancreatic cancer are expected to be diagnosed each year. Chemotherapy, radiation, immunotherapy generally have little effect in controlling pancreatic cancer, and new strategies to control this disease are sorely needed.
Several studies have produced the view that a diet rich in fruits, vegetables, or certain herbs may be protective against various human malignancies, including pancreatic cancer. And this is an area where Indian medicine is light years ahead of us in the U.S. Since 2002, the Amala Cancer Research Center in India, under the direction of Dr Ramadas Ruttan, has been studying the efficacy of Triphala, a blend of three specific fruits common to India. Triphala is commonly known throughout Asia as the King of Medicines., due to the wide range of ailments Ayurvedic practitioners treat with it
During 2006 follow up studies, scientists discovered that Triphala can induce cytotoxicity in cancerous tumor cells while sparing normal, healthy cells. Further studies then revealed that Triphala also killed cancer cells before they could spread, preventing metastasis.
In April of 2007, The University of Pittsburgh Cancer Institute released its findings of a study confirming that Triphala caused pancreatic cancer cells to die through a process known as apoptosis - the body's normal method of disposing of damaged or unneeded cells. This process of apoptosis is often faulty in cancer cells.
The investigators went a step further and looked at the individual fruits in the Triphala blend: Amla, Bibipaki, Haritaki; fruits unique to India. While the Triphala blend of the three fruits triggered cancerous cells to die off, significantly reducing the size of tumors, using the individual components of the blend did not yield any corresponding result. In all cases where Triphala was used successfully, side effects were virtually non-exixtent and no healthy cells were damaged.
Dr Sanjay K Srivastava PhD, lead investigator, is very encouraged with the results, believing that they are on the verge of developing a truly effective treatment protocol for pancreatic cancer The problem waiting in the wings, ready to spring through, is the invariable opposition to anything threatening the profit picture of the U.S. pharmaceutical industry. Triphala cannot be patented. It's readily available in any Indian health food store, and it's cheap. So we can all expect an aggressive media assault to be mounted soon, denouncing Triphala as "quackery," that needs to be banned.
Meanwhile, anyone afflicted with pancreatic cancer would do well to consult a knowledgeable alternative physician and get treated with this substance before our political process is persuaded to outlaw it.
For unbiased commentary on health and wellness issues, health book and health product reviews, alternative medicine practitioner referrals, pet product reviews, skin care, and fitness, and a direct link to the world's premiere manufacturer of supplements that meet and exceed all the requirements outlined here, visit http://www.lequadrillage.com Werner
Article Source: http://EzineArticles.com/?expert=Werner_Knoepp
